239 related articles for article (PubMed ID: 9216736)
1. Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.
Seliger B; Höhne A; Jung D; Kallfelz M; Knuth A; Jaeger E; Bernhard H; Momburg F; Tampé R; Huber C
Exp Hematol; 1997 Jul; 25(7):608-14. PubMed ID: 9216736
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.
Seliger B; Hohne A; Knuth A; Bernhard H; Meyer T; Tampe R; Momburg F; Huber C
Cancer Res; 1996 Apr; 56(8):1756-60. PubMed ID: 8620489
[TBL] [Abstract][Full Text] [Related]
3. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
[TBL] [Abstract][Full Text] [Related]
7. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.
Kallfelz M; Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
Int J Cancer; 1999 Mar; 81(1):125-33. PubMed ID: 10077163
[TBL] [Abstract][Full Text] [Related]
8. A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression.
Garbi N; Tiwari N; Momburg F; Hämmerling GJ
Eur J Immunol; 2003 Jan; 33(1):264-73. PubMed ID: 12594855
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity.
Schendel DJ; Falk CS; Nössner E; Maget B; Kressenstein S; Urlinger S; Tampé R; Gansbacher B
Gene Ther; 2000 Jun; 7(11):950-9. PubMed ID: 10849555
[TBL] [Abstract][Full Text] [Related]
10. Analysis of expression of MHC class I molecules and TAP genes in malignant human cell lines.
Kaczmarek M; Frydrychowicz M; Rubis B; Mizera-Nyczak E; Nieruchalska E; Sikora J; Kaczmarek E
Folia Histochem Cytobiol; 2007; 45(3):205-14. PubMed ID: 17951169
[TBL] [Abstract][Full Text] [Related]
11. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
Wang F; Li X; Annis B; Faustman DL
Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
[TBL] [Abstract][Full Text] [Related]
12. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
13. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
Levitt JM; Howell DD; Rodgers JR; Rich RR
Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules.
Knittler MR; Alberts P; Deverson EV; Howard JC
Curr Biol; 1999 Sep; 9(18):999-1008. PubMed ID: 10508608
[TBL] [Abstract][Full Text] [Related]
15. Peptide loading of nascent MHC class I molecules.
Vukmanović S; Lilić M; Santori FR; Demaria S; Kulig K
Arch Immunol Ther Exp (Warsz); 2001; 49(3):195-201. PubMed ID: 11478393
[TBL] [Abstract][Full Text] [Related]
16. MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding.
Ortmann B; Androlewicz MJ; Cresswell P
Nature; 1994 Apr; 368(6474):864-7. PubMed ID: 8159247
[TBL] [Abstract][Full Text] [Related]
17. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
18. Translocation of long peptides by transporters associated with antigen processing (TAP).
Koopmann JO; Post M; Neefjes JJ; Hämmerling GJ; Momburg F
Eur J Immunol; 1996 Aug; 26(8):1720-8. PubMed ID: 8765012
[TBL] [Abstract][Full Text] [Related]
19. Assessment of intracellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma cells from patients with multiple myeloma.
Crucian BE; Moscinski LC; Androlewicz M; Ballester OF; Widen RH; Yu H
Br J Haematol; 1997 Aug; 98(2):426-32. PubMed ID: 9266943
[TBL] [Abstract][Full Text] [Related]
20. LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.
Rotem-Yehudar R; Groettrup M; Soza A; Kloetzel PM; Ehrlich R
J Exp Med; 1996 Feb; 183(2):499-514. PubMed ID: 8627162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
